Article: Two brokers axe price targets on Danish Genmab.

NORDIC BUSINESS REPORT-9 November 2009-Two brokers axe price targets on Danish Genmab(C)1994-2009 M2 COMMUNICATIONS http://www.m2.com

9 November 2009 - UBS and ABG Sundal Collier reduced their share price targets on Danish biotech company Genmab A/S (CPH: GEN) and maintained their recommendations at "neutral" and "sell", ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!